Cite
HARVARD Citation
Azam, M. et al. (n.d.). Ustekinumab Administration Prior to Week Eight Following Induction Improves Symptoms and Maintains Remission of Severe Crohn's Disease: A Case Series. American journal of gastroenterology. p. . [Online].